Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TAK · against 54 other Healthcare companies of similar size
Ranked #43 of 55 · scores higher than 22% of peers · safety percentile 20
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)5 peers with a safety percentile of 10–19, including TAK · Click a bar to see the companies
Mainly because of its current ratio and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TAK | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 51 reported | 0.73× | 0.55× | 32% | 33% | |
| BetaLower is better · 52 reported | 0.10 | 0.59 | 90% | 33% | |
| Current ratioHigher is better · 53 reported | 1.14× | 1.74× | 29% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 327.3B CNY (≈$45.8B) | 92 | 75 | |
| 2 | 56.7B USD | 85 | 79 | |
| 3 | 8.24T JPY (≈$56.0B) | 83 | 75 | |
| 4 | 4.25T INR (≈$51.0B) | 81 | 70 | |
| 5 | 41.6B USD | 79 | 34 | |
| 39 | 48.5B EUR (≈$53.4B) | 21 | 53 | |
| 40 | 540.4B BRL (≈$97.3B) | 21 | 64 | |
| 41 | 45.9B USD | 21 | 61 | |
| 42 | 97.5B USD | 20 | 67 | |
| 43 | 66.3B USD | 20 | 30 | |
| 44 | 33.3B USD | 19 | 24 | |
| 45 | 36.4B USD | 19 | 50 | |
| 46 | 36.0B USD | 18 | 46 | |
| 47 | 126.1B USD | 12 | 62 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score